Healthcare imaging software
Pro Medicus develops and sells software for hospitals and imaging providers to view, manage, and share medical images and related patient information.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pro Medicus Ltd
XMUN:PMC
|
AU |
|
M
|
Mercedes-Benz Group AG
XBSE:DAI
|
DE |
|
H
|
Hyflux Ltd
XMUN:HYF
|
SG |
|
T
|
Transocean Ltd
SWB:TOJ
|
CH |
|
E
|
Easy Holdings Co Ltd
KOSDAQ:035810
|
KR |
|
Takeda Pharmaceutical Co Ltd
LSE:0A87
|
JP |
|
L
|
Lululemon Athletica Inc
F:33L
|
CA |
|
Westgold Resources Ltd
F:0W2
|
AU |
Pro Medicus makes medical imaging software for hospitals, radiology groups, and other healthcare providers. Its main product is Visage, a system that helps doctors store, view, share, and interpret scans such as X-rays, CTs, and MRIs on fast digital workstations and cloud-based setups. The company does not sell medical devices or run clinics; it sells software that sits in the workflow between imaging equipment and the clinicians who read the images.
The company earns money mainly by licensing its software and charging customers for implementation, support, and ongoing use. Its customers are large health systems and imaging networks that need reliable tools to handle heavy imaging volumes and connect many users across sites. Because the software is used in daily clinical work, contracts can be sticky once installed.
What makes Pro Medicus different is that it focuses on a narrow but critical part of healthcare IT: making medical images load quickly, scale across large hospital networks, and fit into existing reading workflows. That puts it in the role of a specialized infrastructure vendor rather than a broad hospital software supplier. Its business depends on winning long-term relationships with large healthcare buyers that value speed, reliability, and integration with their imaging systems.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more